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Physicians’ motivations to use mobile health monitoring: A cross-country comparison 
 
Abstract 
While mobile device receives increasing attention as a practical tool to remotely check 
patients’ health, little research has shed light on physicians’ acceptance of this information 
and communication technology. This study attempts to fill this research gap by examining 
how Japanese and Spanish physicians perceive a series of factors associated with mobile 
diabetes monitoring acceptance, and whether any differences exist in these perceptions 
between the countries due to different levels of physician scarcity, which is operationalized as 
the number of physicians available per 10,000 population. The hypotheses were tested by 
empirical surveys in Japan and Spain. In total, 471 and 497 usable responses were obtained 
from Japanese and Spanish physicians, respectively. In both countries, physicians were likely 
to embrace clinical expectations (perceived value) and appreciate the ability to check 
patients’ health remotely (ubiquitous control) as the main benefits of mobile diabetes 
monitoring. In terms of cross-country comparison, the influence of personal innovativeness 
on perceived value and ubiquitous control was stronger in Japan (greater physician scarcity), 
compared with Spain (less physician scarcity).  
 
Keywords: health information technology, mobile health, physicians, technology assessment, 
telemedicine 
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Physicians’ motivations to use mobile health monitoring: A cross-country comparison 
 
1. Introduction 
Following unprecedented growth in information and communication technology 
(ICT) during the past decade, health-care experts throughout the world have explored the 
possibilities of utilizing telemedicine (Aas 2003; Holden and Karsh 2009). Telemedicine is 
defined as health-care service, consultation, and expertise delivered via a telecommunications 
medium, over any distance (Priyan 2013). 
The gradual but steady shift toward telemedicine is a clear response to important 
overall problems that most industrialized countries have been facing―the increasing elderly 
population and changing dietary habits. Such an aging population is a likely cause of 
substantial increases in health-care expenditures, while dietary changes have been causing an 
increase in chronic diseases, such as diabetes and hypertension (Seto et al. 2011). In addition, 
rural residents often confront limited accessibility to care outside of hospitals, due to the 
absence of sophisticated outpatient and diagnostic services (Iezzoni et al. 2006). Furthermore, 
there are difficulties in recruiting and retaining personnel in health-care services in general, 
and in home and elderly care in particular (Koch 2006). 
Among the various alternative telemedicine systems, mobile health monitoring has 
been receiving increasing attention in recent years (Chatterjee et al. 2009, Junglas et al. 2009, 
Sneha and Varshney 2013, Wu et al. 2011.). A review of the diabetes self-monitoring 
industry by Chomutare et al. (2001) found 101 applications on the online vendor markets, 
including those for insulin and medication recording, data export and communication, diet 
recording, and weight management. According to a survey by PricewaterhouseCoopers 
(PricewaterhouseCoopers 2010), as much as 40% of U.S. adults would pay for a mobile 
health monitoring service that sends health information directly to their doctor. Even more 
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importantly, 87% of physicians prefer that their patients be able to track and/or monitor their 
health at home, particularly their weight, blood sugar levels, and vital signs. Furthermore, 
57% of physicians said they would like to use remote devices to monitor their patients 
outside of the hospital (PricewaterhouseCoopers 2010). Such data implies that mobile-based 
medical decision support has higher potential, and needs to be explored further in terms of its 
acceptance and feasibility.  
 This study examines physicians’ motivations to use mobile health monitoring in two 
ways. First, focusing on a monitoring system for one of the most common causes of death, 
type 1 diabetes (National Institutes of Health 2009), we elaborate and test an explicative 
model that consists of the motivations to use mobile diabetes monitoring, including personal 
innovativeness in ICT, innovation characteristics, and usage intention. Second, the study 
compares physicians’ answers to a questionnaire survey in two industrialized countries, Japan 
and Spain, where we collected 471 and 497 usable responses, respectively. In doing so, we 
posit that physician scarcity, which is conceptualized as the number of physicians per 10,000 
population, moderates the relationships among these constructs. Physician scarcity is 
expected to drive a serious need for ICT-based health-care monitoring. The results provide 
some important implications on mobile diabetes monitoring from the physicians’ 
perspectives.  
A comparative study across these countries is motivated by two factors. First, both 
Japan and Spain possess a comprehensive public social security system that fully covers basic 
health-care costs, with very similar medical expenditure as a percentage of GDP as well as 
per capita. However, there is an important difference in terms of the relevant medical 
statistics, such as the number of physicians per 10,000 population or per hospital bed (Table 
1). Second, both countries suffer from accelerating aging with a low birth rate, and will reach 
a very similar societal structure in the near future. Many scholars in demography indicate that 
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the ratio of effective labourers to effective consumers in Japan and Spain will plunge in 20 
years (Lee and Mason 2010). Thus, monitoring chronic disease among the elderly, such as 
diabetes, would become a serious social and economic issue in both countries in the future. 
Due to these similarities and differences in medical and societal factors, we believe that our 
research provides reasonable justification for our hypotheses testing.  
<Please insert Table 1 around here> 
The remaining part of the manuscript is structured as follows: We first provide a 
general background on mobile diabetes monitoring. Next, we present our baseline research 
model with a series of hypothesized relationships among the key constructs, and then 
formulate our cross-country comparison hypotheses. We then describe the methodology used 
in this study in detail, and present the hypotheses testing results. On this basis, we draw 
theoretical and managerial implications. In closing, we recognize important limitations, while 
suggesting future research directions.  
2. Mobile diabetes monitoring 
Mobile health monitoring has received much attention from the health-care industry, 
as consumers are increasingly relying on mobile applications to help them manage their 
health and fitness (Tode 2013). Compared with other telemedicine tools, mobile health 
monitoring provides a more personalized and flexible means of control through which 
physicians can get immediate medical data and achieve continuous control over patients’ 
health. One of the advantages of this monitoring system for patients is the unobtrusive, 
prolonged ambulatory monitoring, which allows for improved quality of life and faster 
response in the case of emergencies (Istepanian et al. 2004).  
One of the more prevalent chronic diseases today is diabetes mellitus, characterized 
by an abnormal index of blood glucose (hyperglycemia). According to estimates by the 
World Health Organization, more than 347 million people in the world have diabetes. This 
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figure is expected to double before 2030, and related deaths will multiply by two between 
2005 and 2030 (World Health Organization 2012). In pursuing quality care in diabetes, ICT 
enhances efficient collaboration between physicians and patients (Krishna and Boren 2008). 
In particular, an increasing number of specialists view mobile device as an effective tool for 
diabetes management at a distance (Liang et al. 2011, Liu and Ogwu 2012). Hence, mobile 
diabetes monitoring has received much attention in recent years because it enables the 
following functions: (a) self-monitoring of blood glucose, weight, physical activity, diet, 
insulin and medication, and blood pressure; (b) disease-related data export and physician–
patient communication; and (c) synchronization with personal health record systems at the 
hospital’s information hub (Chomutare et al. 2001). 
The literature on mobile-based medical decision support has been steadily increasing, 
while important studies on mobile diabetes monitoring have been published in patient care or 
health-care settings (Chatterjee et al. 2009, Junglas et al. 2009, Sneha and Varshney 2013, 
Wu et al. 2011). In contrast, much of the research in the medical informatics deals with 
clinical trials. According to a literature review by Liang et al. (2011), 22 clinical trials have 
been documented between 1990 and 2010. Their meta-analysis concluded that research on 
type 2 diabetes led to significant reduction of HbA1c, compared with research on type 1 
diabetes, with reduced costs ranging from less than 1€ to 10€ per month (e.g., Kollmann et al. 
2007, Rossi et al. 2009). Kollmann et al. (2007) conducted a pilot test with 10 type 1 diabetes 
patients. The patients perceived mobile diabetes monitoring as easy to learn and practical for 
regular daily use. Similar results were reported by García-Sáez et al. (2009), Kim et al. 
(2010), and Peña et al. (2009), among others, who collectively reported a high level of 
patients’ acceptance and favourable attitude toward the system. 
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These studies crystallize two important research needs. First, past studies focused on 
patients’ points of view, while little attention was paid to physicians’ perspectives. Second, 
cross-country comparison on mobile diabetes monitoring is almost non-existent.  
3. Research model 
3.1. Overview of the model 
Figure 1 shows our research model, which synthesizes a stream of past studies based 
on diffusion of innovation theory (Agarwal and Prasad 1998, Rogers 1983, Yi et al. 2006). 
According to this theory, there are five elements affecting a new innovative technology that 
will each partly determine whether adoption or diffusion of a new activity will occur: relative 
advantage, compatibility, complexity, trialability, and observability (Rogers 1983). This 
study focuses mainly on relative advantage and compatibility.  
The way in which physicians perceive innovation characteristics of mobile diabetes 
monitoring is largely dependent on their personal innovativeness in ICT, which can be 
defined as the propensity to be in quest of novel ICT. In general, innovation diffusion 
research has long recognized that highly innovative individuals are active information seekers 
for new ideas (Lu et al. 2005). In our study context, physicians who are prone to seek 
innovative ICT would be more motivated to use mobile diabetes monitoring. Next, drawing 
upon the diffusion of innovation theory, Yi et al. (2006) proposed three innovation 
characteristics of a new ICT as the direct drivers of usage intention. More specifically, their 
model examined usefulness (relative advantage in the diffusion of innovation theory), ease of 
use (complexity), and compatibility as determinants of the innovation’s adoption outcomes. 
Similarly, this study focuses on relative advantage and compatibility of mobile diabetes 
monitoring. Rogers (1983) defines relative advantage as the degree to which an innovation is 
perceived as better than the idea it supersedes. We envisage relative advantage of mobile 
diabetes monitoring as two main factors, perceived value and ubiquitous control. Here, 
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perceived value is understood as utility and advantage of the device, while ubiquitous control 
refers to the ability to check a patient’s health regardless of time and place. We view 
compatibility of a new ICT as a measure of the degree to which an innovation is perceived as 
being compatible with existing capability, values, past experiences, and the needs of potential 
adopters. The new device must fit not only physicians’ clinical routines (Melas et al. 2013), 
but also their medical beliefs that remote control of chronic disease is beneficial (Sanson-
Fisher 2004).  
<Please insert Figure 1 around here> 
 These innovation characteristics turn out to be the main causes of usage intention. In 
addition, we posit that innovation characteristics would fully mediate the impact of personal 
innovativeness on intention to use mobile diabetes monitoring. The rationale behind this 
mediation hypothesis is that Yi et al. (2006) found that the impact of personal innovativeness 
on intention to use a personal digital assistant was hardly significant in the presence of the 
innovation characteristics between the two variables. Several past studies corroborate the 
importance of personal innovativeness in directly determining user perceptions of innovation 
characteristics (Lu et al. 2005, Jeyaraj et al. 2006). 
 In the following sections, we explain our theoretical rationale for each dimension and 
formulate a series of hypotheses.  
3.2. Personal innovativeness in ICT and innovation characteristics 
Personal innovativeness has been identified as one of the most important determinants 
in new technology adoption. Prior research offers similar terms, such as arousal seeking 
(Mehrabian and Russell 1974) or venturesomeness (Rogers 1983). This study adopts inherent 
novelty seeking, which is defined as “an individual’s inherent innovative personality, 
predisposition, and cognitive style toward innovations” (Dabholkar and Bagozzi 2002, p. 62). 
Research on the diffusion of innovation is generally in accord with the proposition that the 
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predisposition to acquire new information, ideas, and products is generally derived from 
personal innovativeness. Consumers high in personal innovativeness are more likely to look 
favourably on ICT, and have a stronger intrinsic motivation to use such products (Dabholkar 
and Bagozzi 2002). Because mobile diabetes monitoring is considered a new ICT, personal 
innovativeness could be considered as one of the main drivers for its adoption; that is, the 
greater the personal innovativeness in ICT, the higher the likelihood to perceive relative 
advantage and compatibility of mobile diabetes monitoring.  
While perceived usefulness has been one of the most widely accepted constructs in 
information system (IS) adoption research, prior health research indicates the importance of 
value creation in clinical services. Porter (2009) argued that the central focus of a health-care 
system must be on increasing value for patients; in other words, the health outcomes achieved 
per dollar spent. In addition, the management literature provides consistent evidence that ICT 
may indeed contribute to the improvement of organizational performance, and is often 
viewed as a tool whose intended purpose is to generate value (Melville et al. 2004). 
Furthermore, research on health-care service suggests that “patients arrive at a perceived 
value of service through a trade-off between benefits arising from the services received and 
the costs paid to get the service” (Yoon et al. 2007, p. 376). We posit that physicians who are 
more prone to use innovative ICT would perceive mobile device to be more value-added, and 
thus see more incentive to adopt that tool (Vlahos and Ferratt 1995). Thus: 
H1a. Personal innovativeness in ICT will directly and positively affect perceived value. 
H1b. Perceived value will directly and positively affect intention to use mobile diabetes 
monitoring. 
Ubiquity has been pointed out as the most unique property of mobile device (Chen et 
al. 2012). Similar to our proposition related to perceived value, people with more innovative 
behaviour in ICT adoption are more likely to perceive mobile device as unique due to its 
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flexibility in time and space. Prior research views ubiquity as the most beneficial attribute of 
mobile services (Okazaki et al. 2009). Watson et al. (2002) describe ubiquity as synonymous 
with omnipresence: “not only that they are everywhere but also that they are, in a sense, 
‘nowhere,’ for they become invisible as we no longer notice them” (p. 332). However, 
perhaps a more commonly accepted notion of ubiquity in the context of mobile services has 
been the combined flexibility of space and time (Okazaki et al. 2009, Kleijnen et al. 2007) or 
time criticality ﬁt in patient care settings (Junglas et al. 2009). We contemplate that 
physicians with a high propensity to adopt innovative ICT are more likely to appreciate this 
unique feature of mobile device, and thus develop a higher motivation to use mobile diabetes 
monitoring. More formally: 
H2a. Personal innovativeness in ICT will directly and positively affect ubiquitous control.  
H2b. Ubiquitous control will directly and positively affect intention to use mobile diabetes 
monitoring. 
 Compatibility refers to a notion of “fit” to the intended users’ values, norms, beliefs, 
and perceived needs (Aubert and Hamel 2001). Users can be considered on the individual or 
organizational levels. The concept of reinvention, sometimes identiﬁed as a distinct feature of 
innovation (Greenhalgh et al. 2004), can also be thought of as an extension of compatibility 
(Oldenburg and Glanz 2008). In fact, prior research indicates a strong relationship between 
personal innovativeness and compatibility (Yi et al. 2006). Since mobile diabetes monitoring 
is an innovative form of telemedicine, compatibility holds a key for its adoption. In their 
seminal work on mobile technology in patient care settings, Junglas et al. (2009) found 
workﬂow ﬁt, referring to “the ﬁt between the need to streamline the workﬂow and the 
perceived technological capabilities to support this need,” to be one of the most important 
determinants in its utilization. If physicians can adapt, change, and modify the device or 
system functionality to suit their own clinical needs and context, it will be adopted more 
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easily. Otherwise, physicians might perceive a new ICT tool as a perceived threat to 
professional autonomy that would negatively affect their usage intention (Walter and Lopez 
2008). Taken together, it seems reasonable to assume:  
H3a. Personal innovativeness in ICT will directly and positively affect compatibility.  
H3b. Compatibility will directly and positively affect intention to use mobile diabetes 
monitoring. 
3.3. Physician scarcity as a moderator 
We conceptualize physician scarcity as a moderator of ICT-based remote health 
monitoring adoption. For example, due to shortages of primary medical care, if a physician is 
unable to spend enough time with his or her patients or get in touch with them frequently, the 
quality of patient care would decrease since physician–patient communication plays a role in 
patient concern about chronic disease control (Friedman et al. 2008). Thus, the frequency of 
contact and the amount of time spent with physicians may affect the need for ICT-based 
remote health monitoring. In general, it seems reasonable to assume that the fewer the 
number of physicians per a given number of patients, the greater the need for remote health 
monitoring, since the time for a physician to spend with one patient would be smaller and that 
physician would need an alternative method to reach the patient from a distance; for example, 
remote health monitoring via smartphone. Therefore, our primary thesis is that the more 
serious the physician scarcity, the stronger the physicians’ perceived benefits resulting from 
the use of mobile diabetes monitoring, because the need to remotely provide health-care 
service is greater.  
One of the objective measures for physician scarcity is the physician–patient ratio. 
According to the World Health Statistics (World Health Organization 2012), the number of 
physicians per 10,000 population varies considerably across countries. For example, in Japan, 
France, and the U.S., approximately 20 physicians are available for every 10,000 population, 
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while in Spain, Portugal, and Ireland, this number exceeds 35 (Table 1). Such a statistic 
seems to represent the “distance” between a physician and a patient that needs to be resolved 
by a new ICT device. Specifically, we believe that a mobile monitoring system would help 
physicians to reduce the existing issues related to physician scarcity by remotely checking 
their health conditions. ICT-based health monitoring would also be beneficial for health-care 
organizations in terms of cost reduction.  
 The above discussion leads us to posit that, in a country with greater physician 
scarcity, physicians with a high propensity to adopt innovative ICT would perceive greater 
value and ubiquity of such a device, and they would be more capable of using it. More 
formally: 
H4. The relationship between personal innovativeness in ICT and innovation characteristics 
will be stronger in a country with greater physician scarcity, when compared to a country 
with less physician scarcity, in terms of: (a) perceived value, (b) ubiquitous control, and (c) 
compatibility. Thus: 
H5. The relationship between innovation characteristics and intention to use mobile diabetes 
monitoring will be stronger in a country with greater physician scarcity, when compared to a 
country with less physician scarcity, in terms of: (a) perceived value, (b) ubiquitous control, 
and (c) compatibility. 
4. Method 
This study adopted quantitative research paradigm, in which an online questionnaire survey 
was employed for the data collection with nationally representative physicians.   
4.1. Data collection 
The survey participants were recruited by professional research firms in Japan and 
Spain. In neither country was the sampling method probabilistic. Yet, quota sampling was 
applied in an attempt to ensure the nationally representative sample, in a sense that the 
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respondents were collected from all geographical regions, while the quota of physicians per 
region was weighed by the size of its population. For example, in Japan, the respondents were 
collected from 47 prefectures. In Spain, the respondents were drawn from 17 autonomous 
communities. Thus, the sample distribution was not skewed toward certain regions.  
The standardized survey procedure was applied in both countries in an attempt to 
obtain comparable results and minimize data collection bias. The questionnaire was first 
prepared in English, and then translated into the local language (i.e., Japanese and Spanish). 
The translated version was then back-translated into English in order to ensure the semantic 
equivalency. At the beginning of the questionnaire, we asked the medical specialty of the 
respondents and their level of clinical experience (in years).  
We then showed a graphical image of self-monitoring of blood glucose. In addition, 
we provided a detailed description of the system purpose, functions, and usage procedure. On 
this basis, we asked whether the respondents had used mobile diabetes monitoring. If the 
answer was affirmative, we then asked them to rate each item according to their usage 
experience; otherwise, their assessments were based on the description provided in the 
questionnaire.  
In the next section, we listed questions related to the model constructs explained in the 
previous section: personal innovativeness, perceived value, ubiquitous control, compatibility, 
and intention to use mobile diabetes monitoring.  
4.2. Measures 
Relevant constructs were adapted from previous research in information systems, 
health care, and consumer behaviour. All constructs were measured by multiple-item scales 
with a 7-point Likert scale, except perceived value. Personal innovativeness in ICT was 
measured by a 4-item scale adapted from Dabholkar and Bagozzi (2002). Perceived value 
was measured by an 8-item semantic differential scale used in Kleijnen et al. (2007). 
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Ubiquitous control was specified as a second-order construct consisting of two first-order 
constructs: time flexibility (3 items) and spatial flexibility (3 items) proposed by Okazaki et 
al. (2009). Compatibility was measured by a 3-item scale adapted from Wu et al. (2007). 
Usage intention was adapted from Dabholkar and Bagozzi (2002). All questionnaire items are 
listed in the Appendix.  
The end of the questionnaire included some demographic questions, such as age, 
gender, and geographical area, along with other relevant questions (e.g., usage experience 
and frequency of Internet and mobile device use).  
 4.3. Sample characteristics 
In total, 471 and 497 usable responses were obtained from Japan and Spain, 
respectively. For the Japanese sample, approximately 20.6% and 10.4% belonged to general 
medicine and surgery, respectively. Almost 8% of the sample included physicians who 
specialized in gastrointestinal medicine. The average clinical experience of the respondents 
was 19.3 years. Approximately 87% and 13% of the respondents were male and female, 
respectively, aged 25–65. For the Spanish sample, the majority of the physicians specialized 
in general medicine (55.6%). The average clinical experience of the respondents was 19 
years. Approximately 52.6% and 47.4% of the respondents were male and female, 
respectively, aged 25–80.  
Next, with regard to the general Internet usage in their medical routine, approximately 
17.2% and 30% of the Japanese and Spanish respondents, respectively, habitually used the 
Internet for their patient care or other clinical practices. In terms of mobile Internet usage, 
both countries exhibited similar patterns. In terms of personal use, approximately 44% and 
42% of the Japanese and Spanish respondents, respectively, accessed the Internet with their 
mobile device on a daily basis. By contrast, 26.9% and 41.1% did not in Japan and Spain, 
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respectively. On average, the respondents had been using the Internet with their mobile 
device for approximately 7 and 2.23 years in Japan and Spain, respectively.  
Furthermore, the usage experience and prior knowledge on mobile diabetes 
monitoring were quite similar in Japan and Spain. As in most of the new technology adoption 
studies, we had to face the difficulty to obtain data from respondents without prior usage 
experience. In fact, only .8% and 1% of the respondents had actually used mobile diabetes 
monitoring in Japan and Spain, respectively. Approximately 26% and 27% of the Japanese 
and Spanish respondents, respectively, were aware of its existence, purpose, and functions 
but had not used it. Approximately 73% of the respondents in Japan, and 72% in Spain, had 
not been well informed.  
4.4. Confirmatory factor analysis 
 Before proceeding with the estimation of the structural model, we performed a full-
sample confirmatory factor analysis (CFA) with six latent constructs using AMOS 19.0 
(Byrne 2001). Perceived ubiquity was conceptualized as a second-order construct, thus time 
flexibility and spatial flexibility were added as separate first-order constructs. To take into 
account the recommendations of such authors as Bagozzi and Yi (1988) and Bollen (1989), 
multiple indices were used to assess the goodness of fit of the overall model: χ2242 = 1883.75, 
CFI = .93, TLI = .92, and RMSEA = .084. In a model with “good” fit, the χ2 statistic should 
not be significant at the 5% level. However, the literature suggests that this index becomes 
too sensitive to larger sample sizes (Hair et al. 2006). The values of the CFI and TLI indices 
should be close to 1, although values between .90 and .95 are considered adequate (Bagozzi 
and Yi 1988, Bollen 1989). The RMSEA index should be close to 0 (Byrne 2001). Thus, all 
the indices, except the χ2 statistic, were in an acceptable range. In addition, all items exhibited 
high standardized loadings on their intended factors. Thus, convergent validity was 
established. The CFA results are summarized in the Appendix. 
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 Next, the internal consistency of multiple measures was assessed using composite 
reliability (CR) and average variance extracted (AVE) (Fornell and Larcker 1981). Unlike 
Cronbach’s alpha, which represents a lower bound estimate of internal consistency due to its 
assumption of equal weightings of items, the CR offers a better estimate of variance shared 
by the respective indicators, since it uses the item loadings obtained within the nomological 
network (Hair et al. 2006). An even stricter reliability indicator is the AVE, which is the 
amount of common variance among latent construct indicators (Hair et al. 2006). As a 
benchmark, researchers generally recommend .70 and .50 as an appropriate level for the CR 
and AVE, respectively, in an exploratory study. All the multiple reflective constructs 
exceeded these criteria. 
 Discriminant validity is the extent to which a construct truly differs from 
neighbouring constructs (Hair et al. 2006). This was assessed from the latent constructs 
correlations matrix, where the square roots of the AVE along the diagonal are reported. The 
correlations between the constructs are reported in the lower left off-diagonal elements in the 
matrix. Fornell and Larcker (1981) suggest that average variance shared between a construct 
and its measures should be greater than the variance shared between the construct and other 
constructs in the model. Thus, discriminant validity is satisfied when the diagonal elements 
(square root of AVE) are greater than the off-diagonal elements in the same row and column.  
4.5. Invariance structure 
Given our comparative purpose for the path strengths between Japan and Spain, we 
tested for the measurement invariance across the samples, according to the procedure 
suggested by Steenkamp and Baumgartner (1998). The unrestricted model was used as a 
baseline model. The resulting goodness-of-fit indices met the widely accepted threshold 
criteria, except the chi-square value. All loadings to their respective factors were significant, 
suggesting configural invariance.  
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The second model tested the invariant factor loadings across the models, restricting 
factor loadings equal across countries. The chi-square difference between the full metric 
invariance model and the baseline model was significant (p < .01), although the other fit 
indices, such as CFI, TLI, and RMSEA, were acceptable. Thus, full metric variance was not 
achieved.  
The literature suggests, however, that full metric invariance is rather unrealistic and 
only partial invariance is required for cross-country model comparison (Netemeyer et al. 
2006). On this basis, we next tested a series of partial measurement invariance models by 
sequentially relaxing the factor loadings of the items. Several items—one of spatial 
flexibility, one of usage intention, and three of perceived value—showed modification 
indices indicative of non-invariant items across the samples, and thus were released. The 
resulting model did not differ significantly from the baseline model (p = .07). Therefore, we 
confirmed evidence of partial metric invariance, which enabled us to assess relations in the 
structural model. 
5. Results 
5.1. Main paths 
The structural paths on the hypothesized relationships between the proposed 
constructs were examined for the full sample with maximum likelihood method using AMOS 
19.0 (Byrne 2001). Most of the indices indicated an adequate model fit, except for the χ2 
statistic. Testing yielded a χ2 value of 2017.63 with 245 degrees of freedom and a probability 
of less than .001. However, as we pointed out previously, it has been widely documented that 
the χ2 statistic tends to be substantial when the sample size is large (Hair et al. 2006). In 
addition, the difficulty of passing this stringent test has been noted elsewhere (Bollen 1989). 
Therefore, it was judged that the multiple indices sufficiently justified the adequacy of the 
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model’s fit to the sample data. The resulting fit indices were CFI = .93, TLI = .92, and 
RMSEA = .086. The structural model results are summarized in Table 2.  
<Please insert Table 2 around here> 
Our H1a posits that personal innovativeness in ICT directly and positively affects 
perceived value. Our structural equation modelling results indicate that this path was indeed 
statistically significant with a solid standardized coefficient (β = .82, p < .01). Thus, H1a was 
supported by our data. H1b proposes the direct causal effect of perceived value over usage 
intention. Our results indicate that this path was modest but statistically significant (β = .18, p 
< .01). Thus, H1b was supported.  
Similarly, H2a predicts that personal innovativeness in ICT will determine the level of 
ubiquitous control. This path exhibited the greatest coefficient that was statistically 
significant (β = .85, p < .01). Thus, H2a was supported. H2b hypothesizes that ubiquitous 
control directly and positively influences usage intention. Our results indicate that this 
relationship was statistically significant (β = .11, p < .05). Therefore, H2b was also 
supported. 
H3a contemplates a significant causal relationship between personal innovativeness in 
ICT and compatibility. Our results provide support for this prediction (β = .84, p < .01), 
supporting H3a. H3b makes a similar prediction for the relationship between compatibility 
and usage intention. According to our structural model results, this was indeed the case (β = 
.57, p < .01). Hence, H3b was supported.  
5.2. Cross-country comparison 
To address H4a–c and H5a–c, multigroup analyses were performed using AMOS 19.0 
with the maximum likelihood method. First, the multigroup baseline model was estimated 
across the countries simultaneously, without placing any equality constraints on the 
hypothesized paths. Their fit indices served as initial points of comparison in addressing 
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whether the proposed structural relationships would hold in the same way across the two 
groups. The chi-square value of the unconstrained model was 2572.36 (p < 0.001), with 511 
degrees of freedom. This is the unconstrained or baseline model as indicated in the first row 
of Table 3. In the second model, the path between personal innovativeness in ICT and 
perceived value was constrained to be equal in both Spain and Japan. This is the equal path 
model. The difference in chi-square values between the constrained and equal path models 
(χ21 = 3.12) suggests that the direct path between personal innovativeness in ICT and 
perceived value was marginally greater for the Japanese sample, compared with their Spanish 
counterpart. This test was repeated for the path between personal innovativeness in ICT and 
ubiquitous control, and the one between personal innovativeness in ICT and compatibility. As 
we can see in Table 3, all three paths were greater in Japan than in Spain but the difference in 
the path between personal innovativeness in ICT and compatibility across countries was not 
statistically significant. This evidence supports our H4a and b, but not H4c.  
<Please insert Table 3 around here> 
In testing H5, we obtained only a marginally significant result for the path between 
perceived value and usage intention. This path was marginally greater for the Japanese 
sample, compared with the Spanish sample, while the other two paths were not statistically 
different across the countries. Thus, only H5a was supported; H5b and c were not.        
6. Discussion 
Our intended contribution of this research was to propose and validate a theoretical 
model, while comparing the relationships among the constructs across countries. The 
moderation is based on physician scarcity, which is operationalized as the number of 
physicians per 10,000 population. To this end, we chose Japan and Spain as the sites of study. 
Our structural equation modeling results offer some insightful implications. 
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Theoretically, our study demonstrates the importance of innovation characteristics—
namely perceived value (H1a-b), ubiquitous control (H2a-b), and compatibility (H3a-b)—in 
adopting mobile diabetes monitoring. Our model replaced relative advantage in the original 
model by Yi et al. (2006) with perceived value and ubiquitous control, primarily because of 
the limited diffusion of this technology. However, our study rather crystallized the 
importance of relative advantage in the framework of the diffusion of innovation theory. In 
other words, our results clearly indicate that clinical value and ubiquitous control are the 
main benefits physicians may perceive (and appreciate) from this new tool. This tendency 
will be stronger for those high in personal innovativeness in ICT.  
Indeed, the paths from personal innovativeness in ICT to these three constructs—
perceived value (H1a), ubiquitous control (H2a), and compatibility (H3a)—were solid, 
indicating strong mediating effects of innovation characteristics between personal 
innovativeness and usage intention, which seems consistent with the findings of Yi et al. 
(2006). That is, physicians’ personal innovativeness per se would not stimulate intention to 
use a new device. Instead, physicians should be able to not only understand, but also 
appreciate perceived value, ubiquitous control, and compatibility of the device. First, 
physicians should see the central focus of health-care systems as value creation for patients 
(Porter 2009), and the new device could make a significant contribution to that focus. 
Second, due to their time constraints, physicians should feel a strong urge to improve their 
patients’ health, regardless of their physical location. Third, physicians should be willing to 
try a new device if it does not significantly alter their clinical routine (Melville et al. 2004, 
Vlahos and Ferratt 1995). Therefore, health-care administrators should provide physicians 
with opportunities to become aware of these three innovation characteristics associated with 
mobile diabetes monitoring.   
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In terms of cross-country comparison, the strength of the path from personal 
innovativeness in ICT to perceived value (H4a) was greater in Japan than in Spain. This 
corroborates our theoretical explanation based on physician scarcity. Since the number of 
physicians per 10,000 population is substantially smaller in Japan, compared with Spain, 
physicians with a greater propensity to innovate ICT may have perceived greater value in 
using mobile diabetes monitoring to improve remote patient care. For the same reason, the 
path from personal innovativeness in ICT to ubiquitous control (H4b) was more accentuated 
in Japan than in Spain, probably because Japanese physicians are more concerned with their 
limitations in clinical capacity, and thus are more willing to take advantage of the most 
important utility in mobile diabetes monitoring—flexibility in time and space. The impact of 
physician scarcity as a moderator of mobile-based clinical device has not been introduced in 
the literature, and thus can be considered as an incremental value of this research. 
On the other hand, while compatibility was found to be a main consequence of 
personal innovativeness in ICT, and a strong determinant of usage intention, there was no 
difference in the path strength across the countries in either path (H4c and H5c). Perhaps this 
result indicates that compatibility may not be a unique determinant of mobile diabetes 
monitoring, but a general determinant of any ICT-based monitoring. 
As for the moderating results for the paths between the three innovation 
characteristics and usage intention, only the path from perceived value to usage intention was 
marginally significant (H5a). This seems consistent with our above arguments on the 
importance of value creation in health care. Given the current limited adoption and usage 
experience, physicians could imagine a situation when this tool can actually be used, only 
when they perceive value. Apparently, Japanese physicians are more likely to see value in 
mobile diabetes monitoring. One possible explanation could lie in the fundamental difference 
between the health-care system in Japan and Spain.  
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The Japanese health-care system can be classified as a Bismarck model, whereas the 
Spanish health-care system is known as a Beveridge model. These models are two polar 
opposite social welfare systems. The Bismarck model is an insurance-based open framework, 
where patients can freely choose from a broad range of private doctors and hospitals. Patients 
consult medical specialists directly and pay for their insurance premiums. In contrast, the 
Beveridge model is a tax-funded public system, where the government owns hospitals and 
employs medical specialists. Because it aims at universal coverage through national health 
systems, the Beveridge model provides much less choice to patients, compared with the 
Bismarck model. In addition, the Beveridge model is known for generating significant 
waiting lists to see specialists and thus provoking patient dissatisfaction. Since physicians are 
employed by the government, their salaries are not linked to productivity; this means there is 
generally less incentive to achieve greater efficiency (Or et al. 2010).  
What our findings apparently indicate is that Japanese physicians may see themselves 
as capable of creating value to health care, due to the more flexible Bismarck model that 
allows much more freedom in their clinical practice. In contrast, Spanish physicians may not 
see this value, due to the more restrictive Beveridge model, where their voluntary and 
additional work to achieve greater efficiency is not linked to any recognition. 
7. Limitations  
There are three important limitations that must be recognized in attempting to make 
our discussion more objective. First and foremost, there may be other factors, besides 
physician scarcity, that could have affected the cross-country differences between Japan and 
Spain. For example, the physicians from the two countries may have perceived mobile 
diabetes monitoring differently due to varying levels of technology readiness (World 
Economic Forum 2013). Second, most of the respondents in both countries had not used the 
system, thus their responses were based on their limited knowledge and similar online device 
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experiences. Third, the proportion of male sample was much greater than that of female 
sample in Japan. This skewed gender balance may have affected the results associated with 
innovativeness in ICT, since prior research indicates males are more prone to use new 
technology than females. Finally, some may argue that our study did not include one of the 
countries with the largest medical expenditures—the U.S. The reason for excluding this 
country was due to the structural difference of the social security system where private, not 
public, medical insurance plays a central role. Yet, public interest in mobile diabetes 
monitoring has been rapidly growing in the U.S., thus a comparative study with Asia and/or 
Europe may be of interest in our future research. 
8. Conclusion 
Besides the fact that smartphones have rapidly penetrated worldwide, there are two 
social concerns for which our study results may be useful. First, both Japan and Spain are 
similar in size and have large rural populations in addition to huge urban centres. Mobile 
diabetes monitoring could be an effective tool to functionally “bridge” the clinical needs of 
rural communities and health-care centres. Second, both countries will soon suffer from an 
accelerating aging population. This elderly populace will become a serious burden for social 
security systems that will need a practical solution, and mobile diabetes monitoring could be 
among the most commonly available alternatives that may not require substantial and 
substantive installations. However, from the patients’ perspectives, the health-care industry 
will need to make greater efforts to improve system usability. Easy input methods and clear 
instructions would help the elderly to learn how to manage such devices.   
A logical extension of this study would be to expand our model and include more 
variables that are directly relevant to health-care services. For example, the notion of 
ubiquitous control could be improved. Recent research indicates that perceived ubiquity 
could be a multidimensional construct consisting of immediacy, continuity, portability, and 
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search ability (Okazaki and Mendez 2013). Our future exploration could examine these 
indictors to find out which dimension of perceived ubiquity has the most influence on 
physicians’ usage intention. In addition, other economic indicators such as costs per patient, 
actual usability, and communication frequency could be included in the model so that more 
specific recommendations could be drawn. 
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Figure 1. Research model 
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Table 1. Relevant medical statistics in Japan and Spain. 
Variables Japan Spain 
Number of physicians per 10,000 population 21.4 39.6 
Number of hospital beds per 10,000 population 137 32 
Number of physicians per hospital bed .16 1.24 
Medical expenditure as % of GDP 9.5% 9.6% 
Medical expenditure per capita (US$) $3,754 $3,032 
Pre-diabetes adults in total populationa 6% 10% 
Median age (years old) 45 40 
Aged over 60 30% 22% 
Source: Social Security Advisory Board 2009, a ≥ 25 years old. 
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Table 2. Structural model results (full sample). 
Structural paths Standardized β 
Personal innovativeness in ICT  Perceived value .82 ** 
Personal innovativeness in ICT  Ubiquitous control .85 ** 
Personal innovativeness in ICT  Compatibility .84 ** 
Perceived value  Usage intention .18 ** 
Ubiquitous control  Usage intention .11 * 
Compatibility  Usage intention .57 ** 
Note: ** p < .01, * p < .05 
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Table 3. Results of multigroup moderation analyses. 
Hypotheses Paths 
Path coefficients in 
unconstrained model 
Chi-square statistics test results 
   Baseline model χ2511 = 2572.36 
H4a Personal innovativeness in ICT  Perceived value 
β(Japan) = .84 (SE = .02) 
β(Spain) = .79 (SE = .03) 
Constrained Model χ2512 = 2575.48 
χ21 = 3.12, p = .08 
H4b Personal innovativeness in ICT  Ubiquitous control 
β(Japan) = .86 (SE = .03) 
β(Spain) = .82 (SE = .03) 
Constrained Model χ2512 = 2591.03 
χ21 = 18.67, p < .001 
H4c Personal innovativeness in ICT  Compatibility 
β(Japan) = .97 (SE = .01) 
β(Spain) = .78 (SE = .04) 
Constrained Model χ2512 = 2572.41 
χ21 = .05, p = .82 
H5a Perceived value  Usage intention 
β(Japan) = .28 (SE = .06) 
β(Spain) = .14 (SE = .09) 
Constrained Model χ2512 = 2574.95 
χ21 = 2.59, p = .10 
H5b Ubiquitous control  Usage intention 
β(Japan) = .23 (SE = .10) 
β(Spain) = .19 (SE = .06) 
Constrained Model χ2512 = 2572.37 
χ21 = .01, p = .92 
H5c Compatibility  Usage intention 
β(Japan) = .37 (SE = .10) 
β(Spain) = .57 (SE = .05) 
Constrained Model χ2512 = 2574.60 
χ21 = 2.24, p = .13 
Note: β = unstandardized coefficients. SE = standard error. 
 
 
 
 
 
